Richard graduated with his PhD from University College London (UCL) in 2013, specializing in the higher order structural analysis of proteins by hyphenated mass spectrometry methods. He has held two post-doctoral positions, his first as a research associate at the University of Michigan and the second as an ORISE fellow at the US FDA, in addition to working for Amgen. Richard joined the Sanofi MSAT Analytical group, Framingham, in mid-2020.

Talks

• Commercial Production Development of a Complex Plasma Protein Therapeutic; Mitigating the Risks of Revisions to Purification Process Consumables